| Literature DB >> 33516483 |
Atefeh Berenjian1, Seyed Davood Sharifi2, Abdollah Mohammadi-Sangcheshmeh1, Mohammad Reza Bakhtiarizadeh1.
Abstract
In this study, the effects of omega-3 fatty acids on egg production, nutrients digestibility, eggs yolk lipid peroxidation, and intestinal morphology in laying hens under physiological stress were investigated. Ninety-six 35-wk-old Lohmann LSL-Lite laying hens were used in 2 × 3 factorial arrangement with 2 levels of dexamethasone (DEX) (0 and 1.5 mg/kg of the diet) and 3 levels of omega-3 fatty acids (0, 0.24, or 0.48% of the diet) in a completely randomized design. At 41 wk of age, the stress groups were continuously fed with a DEX 1.5 mg/kg diet for 1 wk. Egg production, egg mass, feed intake, egg weight, and feed conversion ratio were recorded. In addition, the AME, digestibility of CP, crude fat (CF), and organic matter were measured during the stress induction period. At the end of 41 wk of age, malondialdehyde and cholesterol concentrations in the egg yolk and intestinal morphology were investigated. The results showed that egg production, egg mass (P < 0.0001), egg weight (P = 0.043), and BW (P = 0.0005) were lower in DEX layers. Feed intake was reduced by the interaction between DEX and omega-3 fatty acid (P = 0.042). Malondialdehyde value (P = 0.002) and cholesterol concentration (P = 0.001) in egg yolk increased by DEX administration. The combination of DEX administration and omega-3 fatty acids supplementation was found in the indices of intestinal morphology such as villus height and width and crypt depth (P < 0.05). Administration of DEX decreased the CP digestibility (P < 0.0001) and AME (P = 0.006). Digestibility of CF and AME in the group of 0.48% omega-3 fatty acids were higher (P < 0.05) than those of 0 and 0.24%. In conclusion, we found that dietary omega-3 fatty acids had beneficial effects on gut morphology and nutrient digestibility in laying hens under physiological stress. However, they could not alleviate the negative effects of physiological stress on performance.Entities:
Keywords: digestion; egg yolk; glucocorticoid; laying hen; omega-3 fatty acid
Mesh:
Substances:
Year: 2020 PMID: 33516483 PMCID: PMC7936135 DOI: 10.1016/j.psj.2020.12.002
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Total fat content and fatty acids composition (%) of salomega.
| Fatty acids | Reported | Measured(%) |
|---|---|---|
| DM | 95.6 | 95.1 |
| Total fat | 52 | 51.3 |
| Myristic acid (C14:0) | 3.25 | 2.12 |
| Palmitic acid (C16:0) | 10.94 | 11.37 |
| Stearic acid (C18:0) | 2.97 | 2.88 |
| Arachidic acid (C20:0) | 0.30 | 0.38 |
| Palmitoleic acid (16:1n7) | 3.64 | 3.76 |
| Oleic acid (C18:1 n9) | 34.32 | 35.41 |
| Eicosenoic acid(20:1n9) | 3.76 | 3.46 |
| Erucic acid(22:1n9) | 0.60 | 0.23 |
| Tetracosenoic acid(24:1n9) | 0.37 | 0.16 |
| Linoleic acid (C18:2 n6) | 13.08 | 11.87 |
| γ-linolenic acid (18:3n6) | 0.10 | ND |
| Eicosadienoic acid (20:2n6) | 0.79 | 0.63 |
| Eicosatrienoic acid (20:3n6) | 0.19 | 0.93 |
| Arachidonic acid (C20:4n6) | 0.35 | 0.79 |
| Alpha linolenic acid (C18:3 n3) | 4.34 | 4.92 |
| Eicosapentaenoic acid (C20:5 n3) | 3.72 | 3.62 |
| Docosapentaenoic acid (C22:5n3) | 1.60 | 1.61 |
| Docosahexaenoic acid (C22:6 n3) | 4.61 | 5.43 |
| Other fatty acids | 10.83 | 10.43 |
| Total of saturated fatty acids | 17.92 | 16.75 |
| Total of monounsaturated fatty acids | 50.06 | 43.02 |
| Total of polyunsaturated fatty acids | 32.02 | 29.96 |
| Total of omega-3 fatty acids | 16.57 | 15.58 |
| Total of omega-6 fatty acids | 14.62 | 14.22 |
Abbreviation: ND, not detected.
Fatty acid analysis of Salomega reported by Irish Agritech company (Compiled by: Nutrition Analytical Service, Institute of Aquaculture, University of Stirling).
Ingredient and nutrient composition of basal diets.
| Item (% diet) | Total omega-3 fatty acids (% of diet) | ||
|---|---|---|---|
| Control | 0.24 | 0.48 | |
| Yellow corn | 52.2 | 50.6 | 49.0 |
| Soybean meal | 30.8 | 31.2 | 31.5 |
| Bran wheat | 2.5 | 2.5 | 2.5 |
| Salomega | 0 | 1.5 | 3 |
| Canola oil | 1.83 | 1.58 | 1.36 |
| Dicalcium phosphate | 1.53 | 1.51 | 1.52 |
| Limestone | 6.50 | 6.50 | 6.50 |
| Oyster shell | 3.66 | 3.66 | 3.66 |
| Vitamin–mineral premix | 0.5 | 0.5 | 0.5 |
| DL-Methionine | 0.18 | 0.15 | 0.16 |
| Sodium chloride | 0.15 | 0.15 | 0.15 |
| Sodium bicarbonate | 0.15 | 0.15 | 0.15 |
| Total | 100 | 100 | 100 |
| Calculated nutrients | |||
| AMEn (kcal/kg) | 2,620 | 2,620 | 2,620 |
| CP (%) | 18.5 | 18.5 | 18.5 |
| Crude fiber (%) | 2.64 | 2.67 | 2.71 |
| Calcium (%) | 4.25 | 4.25 | 4.25 |
| Total phosphorus (%) | 0.58 | 0.57 | 0.57 |
| Available phosphorus (%) | 0.43 | 0.43 | 0.43 |
| Lysine (%) | 1.03 | 1.02 | 1.02 |
| Methionine (%) | 0.48 | 0.44 | 0.44 |
| Methionine + cysteine (%) | 0.78 | 0.74 | 0.74 |
| Measured nutrients | |||
| CP (%) | 17.33 | 19.58 | 18.09 |
| Crude fat (%) | 4.58 | 4.87 | 5.81 |
| Total omega-3 fatty acid (%) | 0.031 | 0.245 | 0.507 |
Nondehulled soybean meal (44% CP).
Vitamin and mineral premix supplied per kilogram of diet: vitamin A, 9,000 IU; vitamin D3, 2,000 IU; vitamin E, 18 IU; vitamin K3, 2 mg; thiamin,1.8 mg; riboflavin, 6.6 mg; niacin, 30 mg; calcium pantothenate, 10 mg; vitamin B6, 3 mg; folic acid 1 mg; vitamin B12, 0.015 mg; biotin, 0.1 mg; choline, 500 mg; manganese oxide, 100 mg; ferrous sulfate, 50 mg; zinc oxide, 100 mg; copper sulfate, 10 mg; calcium iodate, 1 mg; sodium selenite, 0.2 mg.
Fatty acids profiles (%) of the experimental diets.
| Fatty acids | Total omega-3 fatty acids (% of diet) | ||
|---|---|---|---|
| Control | 0.24 | 0.48 | |
| Myristic acid (C14:0) | - | 2.536 | 3.027 |
| Palmitic acid (C16:0) | 15.872 | 14.709 | 14.767 |
| Palmitoleic acid (C16:1) | - | 0.720 | 1.225 |
| Stearic acid (C18:0) | 5.488 | 4.586 | 4.657 |
| Oleic acid (C18:1 n9) | 29.450 | 30.350 | 31.188 |
| Linoleic acid (C18:2 n6) | 46.915 | 41.127 | 36.387 |
| Alpha linolenic acid (C18:3 n3) | 2.275 | 3.151 | 3.263 |
| Arachidic acid (C20:0) | - | 0.944 | 1.849 |
| Arachidonic acid (C20:4) | - | 0.787 | 1.424 |
| Eicosapentaenoic acid (C20:5 n3) | - | 0.384 | 0.784 |
| Docosapentaenoic acid (C22:5) | - | 0.160 | 0.340 |
| Docosahexaenoic acid (C22:6 n3) | - | 0.546 | 1.089 |
| Total of saturated fatty acids | 21.360 | 22.775 | 24.300 |
| Total of mono unsaturated fatty acids | 29.450 | 31.070 | 32.413 |
| Total of polyunsaturated fatty acids | 49.190 | 46.155 | 43.287 |
| Total of omega-6 fatty acids | 46.915 | 41.914 | 37.811 |
| Total of omega-3 fatty acids | 2.275 | 4.241 | 5.476 |
| Total of omega-6/total omega-3 fatty acids ratio | 20.786 | 9.883 | 6.904 |
Effects of experimental treatments on production performance in laying hens.
| Item | Egg production (%) | Egg mass (g/hen/day) | Egg weight (g) | Feed intake (g/hen/day) | Feed conversion ratio | |
|---|---|---|---|---|---|---|
| Dexamethasone (mg/kg) | ||||||
| 0 | 98.115a | 61.484a | 62.683a | 108.508a | 1.765b | |
| 1.5 | 88.095b | 54.086b | 61.408b | 98.718b | 1.828a | |
| SEM | 1.056 | 0.657 | 0.426 | 0.566 | 0.021 | |
| Omega-3 fatty acids (%) | ||||||
| Control (0.031) | 94.940 | 58.689 | 61.823 | 106.190a | 1.811 | |
| 0.24 | 92.410 | 57.163 | 61.821 | 103.446b | 1.817 | |
| 0.48 | 91.964 | 57.502 | 62.492 | 101.202b | 1.763 | |
| SEM | 1.294 | 0.804 | 0.522 | 0.694 | 0.026 | |
| Dexamethasone × Omega-3 fatty acids | ||||||
| 0 | Control (0.031) | 97.916 | 61.140 | 62.463 | 110.922a | 1.815 |
| 0 | 0.24 | 98.214 | 61.392 | 62.533 | 107.102a | 1.745 |
| 0 | 0.48 | 98.214 | 61.921 | 63.053 | 107.500a | 1.737 |
| 1.5 | Control (0.031) | 91.964 | 56.238 | 61.184 | 101.458b | 1.808 |
| 1.5 | 0.24 | 86.607 | 52.935 | 61.110 | 99.791b | 1.889 |
| 1.5 | 0.48 | 85.714 | 53.084 | 61.930 | 94.905c | 1.789 |
| SEM | 1.830 | 1.138 | 0.739 | 0.981 | 0.036 | |
| Probability | ||||||
| Dexamethasone | <0.0001 | <0.0001 | 0.043 | <0.0001 | 0.043 | |
| Omega-3 fatty acids | 0.241 | 0.390 | 0.588 | 0.0003 | 0.287 | |
| Dexamethasone × Omega-3 fatty | 0.181 | 0.190 | 0.979 | 0.042 | 0.142 | |
a–cMeans with different superscripts within a column are different at P < 0.05.
Effects of experimental treatments on live BW and relative organ weight in laying hens.
| Item | Live BW(g) | Heart | Liver | Ovary |
|---|---|---|---|---|
| Dexamethasone (mg/kg) | ||||
| 0 | 1408.000a | 0.451 | 2.153b | 3.352 |
| 1.5 | 1244.000b | 0.509 | 2.439a | 3.740 |
| SEM | 25.691 | 0.020 | 0.090 | 0.258 |
| Omega-3 fatty acids (%) | ||||
| Control (0.031) | 1347.000 | 0.515 | 2.295 | 3.729 |
| 0.24 | 1309.000 | 0.462 | 2.258 | 3.709 |
| 0.48 | 1323.000 | 0.463 | 2.334 | 3.199 |
| SEM | 31.471 | 0.025 | 0.110 | 0.316 |
| Dexamethasone | 0.0005 | 0.065 | 0.042 | 0.306 |
| Omega-3 fatty acids | 0.695 | 0.264 | 0.889 | 0.429 |
a,bMeans with different superscripts within a column are different at P < 0.05.
Effects of experimental treatments on MDA and cholesterol in laying hens.
| Item | Yolk cholesterol (mg/g of yolk) | Yolk cholesterol (mg/yolk) | Malondialdehyde (μg/yolk) |
|---|---|---|---|
| Dexamethasone (mg/kg) | |||
| 0 | 11.434b | 192.711b | 0.367b |
| 1.5 | 15.950a | 259.021a | 0.609a |
| SEM | 0.813 | 12.808 | 0.048 |
| Omega-3 fatty acids (%) | |||
| Control (0.031) | 13.762 | 229.417 | 0.509 |
| 0.24 | 14.237 | 237.310 | 0.537 |
| 0.48 | 13.076 | 210.870 | 0.417 |
| SEM | 0.996 | 15.687 | 0.059 |
| Probability | |||
| Dexamethasone | 0.0008 | 0.001 | 0.002 |
| Omega-3 fatty acids | 0.713 | 0.485 | 0.349 |
a,bMeans with different superscripts within a column are different at P < 0.05.
Abbreviation: MDA, malondialdehyde.
Effects of experimental treatments on the morphology of the jejunum in laying hens.
| Item | Villus height (μm) | Villus width (μm) | Crypt depth (μm) | Villus:crypt | |
|---|---|---|---|---|---|
| Dexamethasone (mg/kg) | |||||
| 0 | 1159.534 | 19.973b | 183.415b | 6.324a | |
| 1.5 | 1079.854 | 41.003a | 221.251a | 4.881b | |
| SEM | 30.260 | 2.865 | 4.011 | 0.182 | |
| Omega-3 fatty acids (%) | |||||
| Control (0.031) | 1147.707a | 40.529a | 185.432b | 6.185a | |
| 0.24 | 993.007b | 26.752b | 212.131a | 4.683b | |
| 0.48 | 1218.367a | 24.184b | 209.661a | 5.818a | |
| SEM | 37.061 | 3.509 | 4.903 | 0.221 | |
| Dexamethasone × Omega-3 fatty acids | |||||
| 0 | Control (0.031) | 1267.922a | 16.842b | 159.092e | 7.961a |
| 0 | 0.24 | 1033.405a,b | 23.512b | 164.112d,e | 6.290b |
| 0 | 0.48 | 1177.275a,b | 19.565b | 227.520b | 5.176b,c |
| 1.5 | Control (0.031) | 1027.492b | 64.215a | 211.813b,c | 4.851c,d |
| 1.5 | 0.24 | 952.610b | 29.992b | 260.150a | 3.667d |
| 1.5 | 0.48 | 1259.460a | 28.802b | 191.802c,d | 6.56b |
| SEM | 52.412 | 4.963 | 6.935 | 0.312 | |
| Probability | |||||
| Dexamethasone | 0.079 | <0.0001 | <0.0001 | <0.0001 | |
| Omega-3 fatty acids | 0.001 | 0.008 | 0.001 | 0.0009 | |
| Dexamethasone × Omega-3 | 0.022 | 0.0009 | <0.0001 | <0.0001 | |
a–eMeans with different superscripts within a column are different at P < 0.05.
Effects of experimental treatments on AME and nutrient digestibility in laying hens.
| Item | Organic matter (%) | Fat (%) | Protein (%) | AME(kcal/kg) |
|---|---|---|---|---|
| Dexamethasone (mg/kg) | ||||
| 0 | 67.531 | 77.866 | 33.521a | 2746.466a |
| 1.5 | 64.114 | 79.531 | 17.285b | 2640.628b |
| SEM | 1.206 | 1.655 | 2.217 | 23.374 |
| Omega-3 fatty acids (%) | ||||
| Control (0.031) | 64.668 | 76.095b | 22.862 | 2644.112b |
| 0.24 | 65.343 | 76.203b | 22.567 | 2682.020a,b |
| 0.48 | 67.566 | 83.798a | 30.780 | 2754.508a |
| SEM | 1.478 | 2.027 | 2.715 | 28.627 |
| Probability | ||||
| Dexamethasone | 0.078 | 0.485 | <0.0001 | 0.006 |
| Omega-3 fatty acids | 0.367 | 0.020 | 0.072 | 0.046 |
a,bMeans with different superscripts within a column are different at P < 0.05.